Park Ha Biological Technology Co., Ltd. (PHH) - Cash Flow Conversion Efficiency

Latest as of June 2018: -0.112x

Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (PHH) has a cash flow conversion efficiency ratio of -0.112x as of June 2018. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-55.00 Million) by net assets ($489.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Park Ha Biological Technology Co., Ltd. - Cash Flow Conversion Efficiency Trend (1993–2024)

This chart illustrates how Park Ha Biological Technology Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Park Ha Biological Technology Co., Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Park Ha Biological Technology Co., Ltd. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Park Ha Biological Technology Co., Ltd. (1993–2024)

The table below shows the annual cash flow conversion efficiency of Park Ha Biological Technology Co., Ltd. from 1993 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $1.51 Million $960.47K 0.638x +410.27%
2023-12-31 $1.01 Million $126.54K 0.125x -98.70%
2022-12-31 $150.28K $1.44 Million 9.598x +1014.62%
2021-12-31 $-578.18K $-497.86K 0.861x +372.88%
2017-12-31 $1.66 Billion $303.00 Million 0.182x +339.76%
2016-12-31 $1.76 Billion $73.00 Million 0.041x -29.85%
2015-12-31 $2.05 Billion $121.00 Million 0.059x +942.98%
2014-12-31 $1.57 Billion $-11.00 Million -0.007x -100.44%
2013-12-31 $1.69 Billion $2.71 Billion 1.603x +21.72%
2012-12-31 $1.56 Billion $2.06 Billion 1.317x -30.94%
2011-12-31 $1.46 Billion $2.79 Billion 1.907x +279.11%
2010-12-31 $1.58 Billion $-1.68 Billion -1.065x -224.80%
2009-12-31 $1.50 Billion $1.28 Billion 0.853x -42.86%
2008-12-31 $1.27 Billion $1.89 Billion 1.493x -12.49%
2007-12-31 $1.56 Billion $2.66 Billion 1.706x +252.60%
2006-12-31 $1.55 Billion $748.00 Million 0.484x +70.32%
2005-12-31 $3.22 Billion $915.00 Million 0.284x -53.01%
2004-12-31 $4.15 Billion $2.51 Billion 0.605x -35.09%
2003-12-31 $4.12 Billion $3.84 Billion 0.931x +68.51%
2002-12-31 $2.87 Billion $1.59 Billion 0.553x -33.14%
2001-12-31 $1.78 Billion $1.47 Billion 0.827x +103.14%
2000-12-31 $1.87 Billion $761.00 Million 0.407x -50.36%
1999-12-31 $1.63 Billion $1.34 Billion 0.820x +65.35%
1998-12-31 $1.74 Billion $861.70 Million 0.496x -18.23%
1997-12-31 $1.51 Billion $918.24 Million 0.606x +259.22%
1995-12-31 $4.58 Billion $772.68 Million 0.169x -22.56%
1994-12-31 $4.18 Billion $910.92 Million 0.218x -80.58%
1993-12-31 $498.31 Million $559.19 Million 1.122x --

About Park Ha Biological Technology Co., Ltd.

NASDAQ:PHH USA Household & Personal Products
Market Cap
$13.04 Million
Market Cap Rank
#31099 Global
#9561 in USA
Share Price
$0.39
Change (1 day)
-0.08%
52-Week Range
$0.37 - $41.01
All Time High
$41.01
About

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more